ATE229280T1 - Verbesserungen von kreatin-zusammensetzungen - Google Patents

Verbesserungen von kreatin-zusammensetzungen

Info

Publication number
ATE229280T1
ATE229280T1 AT97924142T AT97924142T ATE229280T1 AT E229280 T1 ATE229280 T1 AT E229280T1 AT 97924142 T AT97924142 T AT 97924142T AT 97924142 T AT97924142 T AT 97924142T AT E229280 T1 ATE229280 T1 AT E229280T1
Authority
AT
Austria
Prior art keywords
creatine
creatine compositions
composition
compositions
conveniently
Prior art date
Application number
AT97924142T
Other languages
English (en)
Inventor
Alan Norman Howard
Roger Charles Harris
Original Assignee
Howard Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26309414&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE229280(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Howard Foundation filed Critical Howard Foundation
Application granted granted Critical
Publication of ATE229280T1 publication Critical patent/ATE229280T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/385—Concentrates of non-alcoholic beverages
    • A23L2/39—Dry compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Confectionery (AREA)
  • Detergent Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT97924142T 1996-05-31 1997-05-30 Verbesserungen von kreatin-zusammensetzungen ATE229280T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9611356.8A GB9611356D0 (en) 1996-05-31 1996-05-31 Improvements in or relating to compositions containing Creatine, and other ergogenic compounds
PCT/GB1997/001476 WO1997045026A1 (en) 1996-05-31 1997-05-30 Improvements in or relating to compositions containing creatine
ZA9710788A ZA9710788B (en) 1996-05-31 1997-12-01 Compositions containing creatine.

Publications (1)

Publication Number Publication Date
ATE229280T1 true ATE229280T1 (de) 2002-12-15

Family

ID=26309414

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97924142T ATE229280T1 (de) 1996-05-31 1997-05-30 Verbesserungen von kreatin-zusammensetzungen

Country Status (17)

Country Link
US (1) US5968544A (de)
EP (1) EP0912110B1 (de)
JP (1) JP3485576B2 (de)
CN (2) CN1220583A (de)
AT (1) ATE229280T1 (de)
AU (1) AU733474B2 (de)
BR (1) BR9709418B1 (de)
CA (1) CA2253580C (de)
DE (1) DE69717815T2 (de)
EA (1) EA001388B1 (de)
ES (1) ES2188945T3 (de)
GB (2) GB9611356D0 (de)
NO (1) NO315837B1 (de)
NZ (1) NZ332408A (de)
PL (1) PL330205A1 (de)
WO (1) WO1997045026A1 (de)
ZA (1) ZA9710788B (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274161B1 (en) * 1996-05-31 2001-08-14 The Howard Foundation Compositions containing creatine in suspension
US6524611B2 (en) 1996-05-31 2003-02-25 The Howard Foundation Compositions containing creatine and creatinine
US8128955B2 (en) 1996-05-31 2012-03-06 The Original Creatine Patent Company Food compositions containing creatine
US7150880B2 (en) * 1996-05-31 2006-12-19 The Original Creatine Patent Co. Ltd. Compositions containing creatine and creatinine and a methyl xanthine
US6168802B1 (en) * 1996-05-31 2001-01-02 The Howard Foundation Compositions containing creatine and aloe vera extract
US7504376B2 (en) 1996-08-12 2009-03-17 Natural Alternatives International Methods and compositions for increasing the anaerobic working capacity in tissues
US5965596A (en) 1997-08-12 1999-10-12 Harris; Roger Methods and compositions for increasing the anaerobic working capacity in tissue
AU6726098A (en) * 1997-02-26 1998-09-18 Skw Trostberg Aktiengesellschaft Creatine-ascorbates, production process
DE19707694A1 (de) * 1997-02-26 1998-08-27 Sueddeutsche Kalkstickstoff Kreatin-ascorbate und Verfahren zu deren Herstellung
WO1999000122A1 (de) * 1997-06-25 1999-01-07 Ipr-Institute For Pharmaceutical Research Ag Verfahren zur reduktion des körpergewichtes
TW404833B (en) * 1997-07-11 2000-09-11 Sueddeutsche Kalkstickstoff A method of producing calcium pyruvates
DE19729786A1 (de) * 1997-07-11 1999-01-14 Sueddeutsche Kalkstickstoff Verfahren zur Herstellung von Calciumpyruvaten
US6159942A (en) * 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
EP1051914A1 (de) * 1999-05-08 2000-11-15 DSM Fine Chemicals Austria GmbH Verwendung von Kreatin als Futterzusatz
CA2373806A1 (en) * 1999-07-06 2001-01-11 Societe Des Produits Nestle S.A. Isotonic juice drink for children
JP2001131065A (ja) * 1999-11-05 2001-05-15 Meiji Seika Kaisha Ltd 体脂肪減少促進剤及び体脂肪減少促進用食品組成物
GB0015617D0 (en) * 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
US6399661B1 (en) 2000-06-26 2002-06-04 Jeffrey M. Golini Oral creatine supplement and method for making same
US6897228B2 (en) * 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
EP1363509B1 (de) * 2001-03-02 2006-10-11 The Howard Foundation Zusammensetzung enthaltend kreatin und kreatinin
DE10133198A1 (de) * 2001-07-07 2003-01-23 Beiersdorf Ag Kreatin enthaltende kosmetische und dermatologische Zubereitungen zur Behandlung und aktiven Prävention trockener Haut und anderer negativer Veränderungen der physiologischen Homöostase der gesunden Haut
DE10136077A1 (de) * 2001-07-25 2003-02-13 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einer Kombination von Kreatinin und/oder Kreatininderivaten mit Kreatin und/oder seinen Derivaten
DE10136076A1 (de) * 2001-07-25 2003-02-13 Beiersdorf Ag Verwendung von Kreatinin und/oder Kreatininderivaten in kosmetischen oder dermatologischen Zubereitungen
US20040052852A1 (en) * 2001-09-25 2004-03-18 Michael Farber Carbohydrate-based delivery system for creatine and other bioactive ingredients
DE10159244A1 (de) * 2001-12-03 2003-06-18 Degussa Bioactives Deutschland Feste und stabile Kreatin/Citronensäure-Zusammensetzung(en) und Kohlenhydrat(e) bzw. deren Hydrate enthaltende Formulierung, Verfahren zu ihrer Herstellung und deren Verwendung
US7067150B2 (en) 2002-04-16 2006-06-27 Scepter Holdings, Inc. Delivery systems for functional ingredients
US20030211133A1 (en) * 2002-05-10 2003-11-13 Special Ops Nutrition, L.L.C. Ingestible composition for enhancing athletic performance
DE10301632A1 (de) * 2003-01-17 2004-07-29 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Kreatin, Kreatinin und/oder seinen Derivaten in Kombination mit Sojabohnenkeimextrakten
US6982098B1 (en) * 2003-05-30 2006-01-03 Fun Unlimited Inc. Nutritional weight loss agent and method
US20050100637A1 (en) * 2003-11-12 2005-05-12 Robert Murray Carbohydrate and electrolyte replacement composition
DE10355711A1 (de) * 2003-11-26 2005-06-16 Beiersdorf Ag Kosmetische und dermatologische Emulsionen, enthaltend Kreatin und/oder Kreatinin und Elektrolytkonzentrationen, einer Ionenstärke von mindestens 50 mmol/l
WO2006026458A2 (en) * 2004-08-25 2006-03-09 Mtor Formulations Ltd. Compositions and methods for activating protein synthesis and deactivating catabolic processes in skeletal muscle
US8283327B2 (en) * 2005-03-19 2012-10-09 Kneller Bruce W Palatinose for enhancing dietary supplement and pharmaceutical delivery
CN101309688B (zh) * 2005-05-23 2016-06-22 自然选择国际公司 持续释放β-丙氨酸的组合物和方法
JP2007209231A (ja) * 2006-02-08 2007-08-23 Japan Organo Co Ltd クレアチン含有食品組成物
CA2642761A1 (en) * 2006-02-23 2007-08-30 Iomedix Sleep International Srl Compositions and methods for the induction and maintenance of quality sleep
WO2007133731A2 (en) * 2006-05-11 2007-11-22 Avicena Group, Inc. Creatine-ligand compounds and methods of use thereof
JP5729808B2 (ja) * 2007-12-13 2015-06-03 ヴァンダ ファーマシューティカルズ インコーポレイテッド αアドレナリン受容体介在状態を治療する方法及び組成物
AU2008334933B2 (en) 2007-12-13 2016-01-21 Vanda Pharmaceuticals Inc. Method and composition for treating a serotonin receptor-mediated condition
DE102007062288A1 (de) * 2007-12-21 2009-06-25 Alzchem Trostberg Gmbh Kreatin-Zubereitung und Verfahren zu deren Herstellung
US8435590B2 (en) 2008-11-24 2013-05-07 Stokely-Van Camp, Inc. Use of novel carbohydrates and carbohydrate blends to provide a sports beverage with increased absorption
EP2269980A4 (de) 2008-12-24 2011-05-18 Vertex Closed Joint Stock Company Creatinamide, verfahren zu ihrer herstellung und wirkstoff zur ausführung einer neuroprotektiven aktion
US8703719B1 (en) 2009-05-18 2014-04-22 Bio-Engineered Supplements And Nutrition, Inc. Method and composition for improved muscle performance
RU2463800C2 (ru) * 2009-09-23 2012-10-20 Закрытое акционерное общество "Академия-Т" Сухой специализированный белково-углеводный продукт для питания спортсменов
US9173422B2 (en) 2009-12-29 2015-11-03 Hill's Pet Nutrition, Inc. Compositions including pyruvate for companion animals and methods of use thereof
JP6584777B2 (ja) * 2015-01-16 2019-10-02 太陽化学株式会社 水分電解質補給飲料用粉末組成物
US11617737B2 (en) 2016-12-15 2023-04-04 Société des Produits Nestlé S.A. Compositions and methods that modulate vitamin D and bone mineral content in a companion animal
BR112020007883A2 (pt) 2017-10-18 2020-11-03 Glanbia Nutritionals (Ireland) Ltd. composições de ácido orgânico nitrogenoso estáveis em prateleira
US11246846B2 (en) 2017-10-23 2022-02-15 Michael S. Tempesta Trisodium citrate compositions having enhanced uptake across digestive mucosa
US11154499B2 (en) 2018-03-27 2021-10-26 Thermolife International, Llc Creatine and/or creatinine compositions and related methods
BR112022003360A2 (pt) * 2019-08-23 2022-05-17 Coca Cola Co Bebidas estáveis de creatina

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL155719B (nl) * 1967-01-20 1978-02-15 Unilever Nv Werkwijze ter bereiding van smaakstofmengsels met een vleessmaak.
NL8100815A (nl) * 1981-02-19 1982-09-16 Unilever Nv Werkwijze ter bereiding van 4-hydroxy-5-methyl-2,3-dihydrofuran-3-on, alsmede werkwijze voor het wijzigen van de organoleptische eigenschappen van levensmiddelen en de aldus verkregen levensmiddelen.
JPS5925663A (ja) * 1982-08-02 1984-02-09 Ajinomoto Co Inc ビ−フフレ−バ−調味料の製造法
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
US4772591A (en) * 1985-09-25 1988-09-20 Peritain, Ltd. Method for accelerated wound healing
GB9215746D0 (en) * 1992-07-24 1992-09-09 Hultman Eric A method of increasing creatine supply depot
US5397786A (en) * 1993-01-08 1995-03-14 Simone; Charles B. Rehydration drink
WO1994017794A1 (en) * 1993-02-03 1994-08-18 Steven Andrew Jennings Blends of glycine derivatives and sugars
JP3213666B2 (ja) * 1994-02-28 2001-10-02 治彦 末岡 クレアチン飲料の製造方法
IT1271687B (it) * 1994-08-04 1997-06-04 Flamma Spa Sali organici idrosolubili della creatina
DE69535104T2 (de) * 1994-11-08 2007-02-08 Avicena Group, Inc., Cambridge Verwendung von kreatin oder kreatinanologen zur behandlung von huntington chorea, morbus parkinson und amyotrophen lateralsklerose
JP3581727B2 (ja) * 1994-11-11 2004-10-27 株式会社日立製作所 ディスクアレイコントローラ及びディスクアレイ装置
JP3595373B2 (ja) * 1995-02-20 2004-12-02 治彦 末岡 クレアチン飲料
IT1275434B (it) * 1995-05-19 1997-08-07 Farmila Farma Milano Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante

Also Published As

Publication number Publication date
PL330205A1 (en) 1999-04-26
NO985532D0 (no) 1998-11-27
AU2970997A (en) 1998-01-05
GB9611356D0 (en) 1996-08-07
DE69717815D1 (de) 2003-01-23
NO315837B1 (no) 2003-11-03
GB2313544A (en) 1997-12-03
EA001388B1 (ru) 2001-02-26
CN1364430A (zh) 2002-08-21
CN1220583A (zh) 1999-06-23
NO985532L (no) 1999-01-26
CA2253580A1 (en) 1997-12-04
EP0912110B1 (de) 2002-12-11
EA199801076A1 (ru) 1999-04-29
EP0912110A1 (de) 1999-05-06
GB9711041D0 (en) 1997-07-23
CA2253580C (en) 2006-10-03
ES2188945T3 (es) 2003-07-01
GB2313544B (en) 2000-01-12
WO1997045026A1 (en) 1997-12-04
JP2000511054A (ja) 2000-08-29
HK1019694A1 (en) 2000-02-25
AU733474B2 (en) 2001-05-17
JP3485576B2 (ja) 2004-01-13
NZ332408A (en) 1999-08-30
DE69717815T2 (de) 2003-11-20
BR9709418B1 (pt) 2011-03-09
US5968544A (en) 1999-10-19
BR9709418A (pt) 2000-01-11
ZA9710788B (en) 1998-08-26

Similar Documents

Publication Publication Date Title
ATE229280T1 (de) Verbesserungen von kreatin-zusammensetzungen
FR2746302B1 (fr) Compositions cosmetiques comprenant des nanopigments
ATE280826T1 (de) Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen
ATE312843T1 (de) Neues cyclosporin mit verbesserter wirkung
BR9710462A (pt) Naftopirans composicoes e artigos contendo as mesmas
DE69729614D1 (de) Beschichtungszusammensetzung mit verbesserter Lagerstabilität
ZA864608B (en) Amino acid derivatives
NO20025004L (no) Fremgangsmåte for fremstilling av 2,5-diketopiperaziner, 2,5- diketopiperaziner, dipeptider samt anvendelse derav
HUP0202799A3 (en) Herbicidal isoxazoline derivatives and composition containing the same
BR9915457B1 (pt) composições de moldagem, uso e artigo.
TR199700049A2 (tr) Düsük CO'lu sigara.
TR199902655A2 (xx) K�k�rt-fonksiyonel poliorganosiloksanlar
PT799578E (pt) Preparacao combinada contendo germes enriquecidos com electrolitos
DE69726231D1 (de) Lichtbildfähige lagerstabile Zusammensetzungen mit verbesserten Leuko-Farbstoffen
ES2176128T1 (es) Genes de corynebacterium glutamicum que codifican proteinas implicadas en la homeostasis y la adaptacion.
IT1309133B1 (it) Perfezionamenti nelle luci elettriche o relativamente alle stesse.
ES2180319T3 (es) Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.
TR200002101T2 (tr) Dondurulmuş gıda ürünü.
NO985382L (no) Lagringsstabile hydrogeler
EP0616800A3 (de) Rieckstoffmittel mit verlängerter Diffusion.
FR2746301B1 (fr) Compositions cosmetiques comprenant des nanopigments
ITMI20030827A1 (it) Composizione farmaceutica contenente l'associazione levodopa/carbidopa.
WO2001072798A3 (en) Regulation of human oatp2-related protein
RU96103721A (ru) Антгельминтное средство
BR8000715U (pt) Disposição introduzida em embalagem

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0912110

Country of ref document: EP